The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Clinical Management Factors Contribute to the Decision for Contralateral Prophylactic Mastectomy
Open accessAbstract
Purpose: To determine whether increasing rates of contralateral prophylactic mastectomy (CPM) are due to recognition of risk factors for contralateral breast cancer (CBC) or treatment factors related to the index lesion. Methods: From 1997 to 2005, 2,965 patients with stage 0 to III primary unilateral breast cancer underwent mastectomy at Memorial Sloan-Kettering Cancer Center. Patients who did and did not undergo CPM within 1 year of treatment for their index cancer were compared to identify independent predictors of CPM. Results: The rate of CPM was 13.8% (n = 407), increasing from 6.7% in 1997 to 24.2% in 2005 (P < .0001). Patients with BRCA mutations or prior mantle radiation (n = 52) accounted for 13% of those having CPM. The rate of CPM by surgeon varied from 1% to 26%. Multivariate logistic regression adjusting for surgeon-identified white race (odds ratio [OR] = 3.3), immediate reconstruction (OR = 3.3), family history of breast cancer (OR = 2.9), magnetic resonance imaging (MRI) at diagnosis (OR = 2.8), age younger than 50 years (OR = 2.2), noninvasive histology (OR = 1.8), and prior attempt at breast conversation (OR = 1.7) to be independent predictors of CPM. Conclusion: These data suggest that increasing use of CPM is not associated with increased recognition of patients at high risk for CBC. Treatment factors, such as immediate reconstruction, preoperative MRI, and unsuccessful attempts at breast conservation, are associated with increased rates of CPM. Efforts to optimize breast conservation, minimize unnecessary tests, and improve patient education about the low risk of CBC may help to curb this trend.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Cuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M., & Forbes, J. F. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70257-6 · Cited by 1,674
Berg, W. A., Gutierrez, L., NessAiver, M. S., Carter, W. B., Bhargavan, M., Lewis, R. S., & Ioffe, O. B. (2004) · Radiology · doi:10.1148/radiol.2333031484 · Cited by 1,439
MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer
Lehman, C. D., Gatsonis, C., Kuhl, C. K., Hendrick, R. E., Pisano, E. D., Hanna, L., Peacock, S., Smazal, S. F., Maki, D. D., Julian, T. B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065447 · Cited by 945
(2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70385-6 · Cited by 919
Houssami, N., Ciatto, S., Macaskill, P., Lord, S. J., Warren, R. M., Dixon, J. M., & Irwig, L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2108 · Cited by 831
Annual hazard rates of recurrence for breast cancer after primary therapy.
Saphner, T., Tormey, D. C., & Gray, R. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2738 · Cited by 830
Tuttle, T. M., Habermann, E. B., Grund, E. H., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3141 · Cited by 661
Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy
Singletary, S. E. (2002) · The American Journal of Surgery · doi:10.1016/s0002-9610(02)01012-7 · Cited by 612
Breast cancer genetics: What we know and what we need
Nathanson, K. N., Wooster, R., & Weber, B. L. (2001) · Nature Medicine · doi:10.1038/87876 · Cited by 466
Prophylactic mastectomy for the prevention of breast cancer
Lostumbo, L., Carbine, N. E., & Wallace, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002748.pub3 · Cited by 400
Katipamula, R., Degnim, A. C., Hoskin, T., Boughey, J. C., Loprinzi, C., Grant, C. S., Brandt, K. R., Pruthi, S., Chute, C. G., Olson, J. E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.4225 · Cited by 373
Gao, X., Fisher, S. G., & Emami, B. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00203-7 · Cited by 372
Surgeon Recommendations and Receipt of Mastectomy for Treatment of Breast Cancer
Morrow, M. (2009) · JAMA · doi:10.1001/jama.2009.1450 · Cited by 333
Self-citationMcGuire, K. P., Santillan, A. A., Kaur, P., Meade, T., Parbhoo, J., Mathias, M., Shamehdi, C., Davis, M., Ramos, D., & Cox, C. E. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0635-x · Cited by 326
Bleicher, R. J., Ciocca, R. M., Egleston, B. L., Sesa, L., Evers, K., Sigurdson, E. R., & Morrow, M. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.04.010 · Cited by 255
Self-citationBedrosian, I., Hu, C.-Y., & Chang, G. J. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq018 · Cited by 215
Jones, N., Wilson, J. L., Kotur, L., Stephens, J. A., Farrar, W. B., & Agnese, D. M. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0547-9 · Cited by 150
Yi, M., Hunt, K. K., Arun, B., Bedrosian, I., Gutierrez‐Barrera, A. M., Do, K.-A., Kuerer, H. M., Babiera, G. V., Mittendorf, E. A., Ready, K. J., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0130 · Cited by 143
Second primary cancers of the breast: Incidence and risk factors
Hislop, T. G., Elwood, M., Coldman, A. J., Spinelli, J. J., Worth, A. J., & Ellison, L. G. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.12 · Cited by 123
The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy
Dupont, E. L., Kuhn, M. A., McCann, C. R., Salud, C., Spanton, J. L., & Cox, C. E. (2000) · The American Journal of Surgery · doi:10.1016/s0002-9610(00)00458-x · Cited by 81
Yi, M., Meric‐Bernstam, F., Middleton, L. P., Arun, B., Bedrosian, I., Babiera, G. V., Hwang, R. F., Kuerer, H. M., Yang, W. T., & Hunt, K. K. (2009) · Cancer · doi:10.1002/cncr.24129 · Cited by 65
McLaughlin, S. A., Stempel, M. M., Morris, E. A., Liberman, L., & King, T. A. (2008) · Cancer · doi:10.1002/cncr.23298 · Cited by 47
Self-citation
Cited by
A Paradigm Shift in U.S. Breast Reconstruction: Increasing Implant Rates
Albornoz, C. R., Bach, P. B., Mehrara, B. J., Disa, J. J., Pusic, A. L., McCarthy, C. M., Cordeiro, P. G., & Matros, E. (2013) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e3182729cde · Cited by 897
Moran, M. S., Schnitt, S. J., Giuliano, A. E., Harris, J. R., Khan, S. A., Horton, J., Klimberg, S., Chavez-MacGregor, M., Freedman, G., Houssami, N., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3481-4 · Cited by 612
Self-citationOverview of Breast Cancer Therapy
Moo, T.-A., Sanford, R., Dang, C., & Morrow, M. (2018) · PET Clinics · doi:10.1016/j.cpet.2018.02.006 · Cited by 551
Self-citationMoran, M. S., Schnitt, S. J., Giuliano, A. E., Harris, J. R., Khan, S. A., Horton, J., Klimberg, S., Chavez-MacGregor, M., Freedman, G., Houssami, N., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.11.012 · Cited by 495
Self-citationLong-term Patient-Reported Outcomes in Postmastectomy Breast Reconstruction
Santosa, K. B., Qi, J., Kim, H. M., Hamill, J. B., Wilkins, E. G., & Pusic, A. L. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2018.1677 · Cited by 468
Metadata
- Authors
- King, T. A., Sakr, R., Patil, S., Gurevich, I., Stempel, M., Sampson, M., & Morrow, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-06-01
- Volume
- 29
- Issue
- 16
- Pages
- 2158-2164
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2111014842
- Cited by
- 330
- References
- 25
- FWCI
- 18.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.